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Technologies for targeted modification of eukaryotic ge-
nomes are of great value for elucidating and manipulating 
gene functions in fundamental and applied biological re-
search. In the past two decades, genome editing tools have 
evolved quickly from random DNA mutagenesis-inducing 
chemicals or ionizing radiation to programmable sequence- 
specific nucleases (SSNs) with the CRISPR/Cas technology 
as the most significant breakthrough (Gaj et al., 2013). 
When the CRISPR/Cas system is still gaining snowballing 
popularity, a recent study from Gao and colleagues pub-
lished in Nature Biotechnology has made another big splash 
in the field of genome editing by identifying the archaeal 
Argonaute protein as a novel type of SSN rivaling the 
CRISPR/Cas technology for genome editing in human cells 
(Gao et al., 2016). By opening up a new avenue for genome 
editing in eukaryotes, this work will undoubtedly pose a 
profound impact on many aspects of biological research.  
Introducing a frameshift mutation or sequence alteration 
at an intended genomic locus leading to gene inactivation or 
functional modification is a common strategy for studying 
unknown gene functions or retuning gene activities related 
to human diseases or agricultural traits. In fact, gene muta-
genesis can occur spontaneously during DNA repair after a 
DNA double-strand break is precisely created at the desired 
site within the target gene, which is what SSNs have been 
designed to fulfill. Homing endonucleases, zinc finger nu-
cleases (ZFNs) and transcription activator-like effector nu-
cleases (TALENs) represent earlier generations of SSNs, 
whose DNA recognition is achieved through DNA-binding 
domains inside the nuclease proteins. Consequently, repro-
gramming new DNA targeting specificity involves sophis-
ticated design and demanding reconstruction of the DNA- 
binding protein domains. These weaknesses also dramati-
cally limit the multiplexability of this type of SSNs. It is 
therefore not surprising that the CRISPR/Cas technology, 
which utilizes a synthetic guide RNA (sgRNA) to ferry the 
Streptococcus pyogenes Cas9 (SpCas9) nuclease to the ge-
nomic target through RNA-DNA complementarity, could 
readily exceed ZFNs and TALENs due to its unprecedented 
simplicity and multiplexability (Doudna and Charpentier, 
2014). Even so, the CRISPR/Cas technology is blemished 
with frequent off-target effects, particularly in mammalian 
cells. The obligatory requirement of a protospacer adjacent 
motif (PAM) in the target sequence and the poor editing 
efficiencies of SpCas9 at targets with extremely low or high 
GC contents also limit the selection of accessible targets in 
a given genome.  
Argonaute proteins are an ancient family of endonucle-
ases that play essential roles in host antiviral defense and 
gene regulation. Eukaryotic Argonautes are guided by small 
single-stranded RNA such as siRNA and miRNA to cleave 
single-stranded RNA targets including endogenous mRNA 
and invading viral RNA. Interestingly, two prokaryotic 
homologues, namely Thermus thermophilus Argonaute 
(TtAgo) and Pyrococcus furiosus Argonaute (PfAgo), were 
found to utilize small 5′-phosphorylated single-stranded 
DNA (ssDNA) as guides to cleave double-stranded DNA 
targets within trespassing plasmids (Swarts et al., 2014; 
Swarts et al., 2015). Although these pioneering findings 
may suggest the possibility of developing DNA-guided ge-
nome editing tools, the high working temperatures (≥65°C) 
of TtAgo and PfAgo, which are far above the physiological 
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temperatures for eukaryotic organisms, make them unsuita-
ble for eukaryotic genome editing.  
The work by Gao and co-workers now breaks the high 
temperature constraint of DNA-guided Argonaute nucleases 
by discovering that the Natronobacterium gregoryi Argo-
naute (NgAgo) was able to cleave target plasmid DNA at 
37°C in both E. coli and human HeLa cells solely with 
5′-phosphorylated ssDNA as guides. They next extensively 
tested the editing of eight different endogenous genes with a 
total of 47 ssDNA guides in several human and mammalian 
cell lines and obtained efficient editing with all guides. In 
particular, the authors demonstrated that the ssDNA-guided 
NgAgo and the sgRNA-guided SpCas9 could lead to com-
parable efficiencies in editing the same plasmid DNA or 
endogenous DYRK1A gene in HeLa cells. Notably, they 
found that NgAgo performed substantially better than 
SpCas9 when aiming at some GC-rich loci within target 
genes. The authors also clarified that the optimal length of 
the ssDNA guide for NgAgo is 24 nt and any single mis-
match between the guide and the target DNA could dramat-
ically compromise the editing efficiencies. They further 
accomplished homology recombination-mediated DNA 
insertion at the DYRK1A gene in human 293T cells with the 
NgAgo system, and found that only SpCas9 but not NgAgo 
led to off-target DNA insertion. 
Evidence presented in this work suggests that the NgAgo 
system may carry a few striking advantages over the 
SpCas9 system. First, NgAgo employs a longer guide se-
quence (24 nt) and exhibits a lower tolerance to guide-target 
mismatches than SpCas9, thus ensuring a higher editing 
specificity; second, NgAgo does not impose any PAM re-
quirement to the target sequence and is highly tolerant to 
GC-rich target sequences, thus offering a much broader 
range of target selection than SpCas9; last but not least, the 
gene size of NgAgo (~2.7 kb) is significantly smaller than 
that of SpCas9 (~4.2 kb) and SaCas9 (~3.3 kb, the smallest 
Cas9 known so far), and 5’-phosphorylated ssDNA guides 
are much cheaper for commercial synthesis and more stable 
than the sgRNA guides, together making the NgAgo system 
more amenable to work with than the CRISPR/Cas system 
during cloning/synthesis and cell delivery.  
It is foreseeable that follow-up exploration will involve 
the co-delivery of NgAgo-encoding plasmids and commer-
cially synthesized 5′-phosphorylated ssDNA into mamma-
lian zygotes via microinjection to generate genome-edited 
whole animals. To enable the NgAgo system to work for  
other important eukaryotic model organisms including 
plants, fruitfly, nematode and zebrafish, improvement will 
be needed to reduce its working temperature down to the 
range of room temperature. Accordingly, it will be neces-
sary to carefully confirm the absence of endogenous small 
5′-phosphorylated ssDNA in these organisms that could 
mislead NgAgo to off-target sites. Although preliminary 
data by Gao and colleagues suggested that NgAgo is highly 
specific in mammalian cells (Gao et al., 2016), systematic 
evaluation of its off-target effects with unbiased whole- 
genome sequencing will be indispensable. In addition, the 
multiplexability of the NgAgo system still awaits evalua-
tion. On the other hand, addressing the fundamental ques-
tions regarding the action mechanisms of NgAgo-based 
immune system in N. gregoryi will be needed, which may in 
turn guide the improvement of the NgAgo system. For in-
stance, understanding the mechanism of how archaea gen-
erate small 5′-phosphorylated ssDNA may inspire us to find 
ways to produce customized ssDNA guides in vivo in eu-
karyotic cells; knowledge about the structural basis of 
NgAgo-ssDNA and NgAgo-target DNA interactions may 
guide the engineering of NgAgo variants allowing ssDNA 
exchange in vivo or adopting lower reaction temperatures. 
Although it is uncertain whether the NgAgo system will 
eventually replace the prevailing CRISPR/Cas system or be 
merely an attractive complement to the latter, there is every 
reason to believe that future efforts investing on this 
groundbreaking technology will pay huge dividend to basic 
and applied biological research.   
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